Soto-Catalán, M., Opazo-Ríos, L., Quiceno, H., Lázaro, I., Moreno, J. A., Gómez-Guerrero, C., . . . Mas-Fontao, S. (2024). Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences, 25(5), 2961. https://doi.org/10.3390/ijms25052961
Chicago Style (17th ed.) CitationSoto-Catalán, Manuel, Lucas Opazo-Ríos, Hernán Quiceno, Iolanda Lázaro, Juan Antonio Moreno, Carmen Gómez-Guerrero, Jesús Egido, and Sebastian Mas-Fontao. "Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease." International Journal of Molecular Sciences 25, no. 5 (2024): 2961. https://doi.org/10.3390/ijms25052961.
MLA (9th ed.) CitationSoto-Catalán, Manuel, et al. "Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease." International Journal of Molecular Sciences, vol. 25, no. 5, 2024, p. 2961, https://doi.org/10.3390/ijms25052961.
